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Abstract 
Aim: The aim of this organisational development project was to introduce a sweat 
test clinic for adult patients’ in a large academic teaching hospital. Rationale: The 
sweat test is used in the diagnosis of cystic fibrosis. The introduction of Ivacaftor, 
trade name Kalydeco®, for a particular subset of cystic fibrosis patients and the 
recognition of milder phenotypes of cystic fibrosis in adults had resulted in an 
increased demand for an adult clinic. Prior to the introduction of the adult service 33 
adults were awaiting sweat test appointments and unable to access a sweat test 
service. Change process: The Health Service Executive change model was used 
as a framework to guide the change process. A vision for the change was created 
and the introduction of the clinic was aligned to the mission of the organisation and 
that of the Health Service Executive, that patients’ will have access to high quality 
health care. Evaluation: The context, input, process and products model was used 
to evaluate the organizational development process. This involved evaluation each 
of the objectives of the project. A target of 8 weeks wait time for an appointment has 
been achieved. Results and conclusions: The adult sweat test service was 
implemented with two out of 14 patients’ having a chloride result indicative of cystic 
fibrosis. A further 19 patients are scheduled for appointment. Use of a structured 
change model guided successful implementation of the clinic. The target 
appointment wait time will require regular auditing by the Clinical Chemistry 
Department to ensure compliance. This will form part of the regular auditing of 
services as part of the overall laboratory quality management system. The service 
will be monitored for any increase or decrease in demand ensuring effective use of 
resources. This is report monthly at the Clinical Chemistry Operational Group 
meeting. 
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1.0 Introduction 
 
1.1 Introduction 
 
The purpose of this organisational development (OD) project was to introduce an 
adult sweat test clinic in the outpatient department (OPD) of an Acute Dublin 
Academic Teaching Hospital (DATH).  Before the introduction of the adult sweat test 
clinic, the organisation provided a paediatric sweat test service. It was envisaged 
that upon implementation of the adult service, both the paediatric and adult sweat 
test clinics would be maintained as a combined service. The OD change was 
achieved through a review of current appointment requests and scheduling 
requirements. Current Hospital CF and infection prevention and control guidelines 
were adhered to when implementing the clinic, ensuring patient safety. Upon 
successful implementation of the service, it was envisaged that the organisation 
would be capable of providing both adult and paediatric sweat test appointments to 
all requesting clinicians, in the appropriate setting and in a timely manner. 
 
This chapter discusses the rationale for the OD project, the organisational context 
within which it was implemented, and the aims and objectives of the project. It will 
also discuss the role of the author within the organisation, and in the change process 
itself. The Health Service Executive (HSE) Change Model (Improving our services: A 
user’s guide to managing change in the Health Service Executive, 2008) was chosen 
to help guide the project.  
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1.2 Organisational Context 
 
The organisation in which the OD project was undertaken is a 625-bed acute 
Hospital. It is a public, voluntary teaching Hospital, providing children's health, adult, 
psychiatric and age-related healthcare on one site (Organisations webpage, n.d.). 
The patient-focused mission of the hospital aligns with the mission of the HSE which 
states that “people in Ireland can access safe, compassionate and quality care when 
they need it”, as outlined in the HSE corporate plan 2015-2017 (Health Service 
Executive, 2015b). The introduction of the HSE Ivacaftor, trade name Kalydeco®, 
Reimbursement Protocol has resulted in an increase in the number of adults 
requiring access to a sweat test clinic. This focus of this project, which reflects the 
mission of the organisation, was the introduction of an adult sweat test service, 
thereby supporting the healthcare system to improve the experience of care 
(Berwick, Nolan, & Whittington, 2008).  
 
 
1.3 Rationale 
 
The Clinical Chemistry Department within the organisation runs an established 
Consultant led sweat test service located in the Paediatric OPD of the Hospital. The 
sweat test is used in the diagnosis of Cystic Fibrosis (CF). The paediatric clinics are 
run on two weekday mornings in a dedicated sweat test room. A trained medical 
scientist from the Clinical Chemistry Laboratory performs the sweat test. The 
appointment service is managed by the clerical staff of the Clinical Chemistry 
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Department, and all sweat tests performed are approved and signed off by either the 
Consultant Chemical Pathologist or Clinical Chemistry Registrar before results are 
made available to the requesting clinician. As the sweat test clinic is organised and 
delivered through the Clinical Chemistry Laboratory, the Consultant Chemical 
Pathologist is accountable for the clinical governance of the service. The Hospital is 
also a referral centre for the CF national newborn screening programme. 
 
Sweat tests in the paediatric clinic are performed on symptomatic children less than 
16 years of age, and on patients identified as having an elevated immunoreactive 
trypsinogen (IRT) as part of the national newborn screening programme. From the 
end of 2014, there was an increase in the demand for sweat tests to be performed 
on patients 16 years of age and over. These requests consisted of symptomatic 
adult patients and previously diagnosed CF patients. The adult CF patients are 
receiving a HSE funded drug, Ivacaftor, which has been successful in treating 
patients with a specific mutation, G551D. A requirement of HSE funding for Ivacaftor 
is that patients receiving treatment undergo an annual sweat test to demonstrate its 
effectiveness (Ivacaftor (Kalydeco) Reimbursement Protocol, n.d.).  
 
The paediatric clinic is located in a designated room of the paediatric OPD. Due to 
child protection issues, it would not be feasible for adult patients to be facilitated in 
this area. The potential for cross infection between external CF patients and 
paediatric patients attending the CF Department in the Hospital was also highlighted 
by the paediatric CF Consultant in the Hospital. Current Hospital protocol ensures 
that CF patients carrying different microorganisms are separated at appointments to 
reduce any unnecessary infection risk. To ensure any cross infection is minimised, 
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the room in which the CF patient has attended is cleaned with specialised equipment 
by the facilities management team within the Hospital. This process is implemented 
according to the infection control guidelines for CF patients set out by the Hospital. 
 
The OD project came about as a result of a number of factors. Screening for CF was 
introduced as part of the newborn screening programme in July 2012. As a result, 
the number of symptomatic patients attending for sweat tests has declined. At the 
same time, there has been an increase in the demand for adult sweat test 
appointments for CF patients receiving Ivacaftor. The CF Department within the 
organisation had expressed concern at the possibility of external CF patients 
attending clinics in the same location as their CF patients. If the clinics for both adult 
and paediatric patients were situated in proximity, this would increase the potential 
cross infection risk between CF patients. In addition to the adult CF patients, there 
has also been an increase in the number of clinicians requesting a sweat test on 
symptomatic adult patients.   
 
Due to the coexistence of both paediatric and adult services within the organisation, 
the hospital has become a referral centre for both adult and paediatric sweat test 
requests. Adult hospitals within the catchment area would previously have had no 
requirement to provide a sweat test service, as patients are more likely to be 
diagnosed before adolescence. The Clinical Chemistry Laboratory within the 
organisation has access to all necessary training and equipment required to perform 
a sweat test. The current service provided by the laboratory is required to adapt to 
meet the demands of the clinicians using the service. This is also in line with the 
HSE National Service Plan 2016 where the focus is on reducing waiting list and 
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improving quality of care for patients who require access to health services (Health 
Service Executive, 2016). 
 
 
1.4 Aims and Objectives 
 
An objective is a specific statement or statements of the outcomes to be achieved as 
a result of a planned change (Improving our services: A user’s guide to managing 
change in the Health Service Executive, 2008). Specific, measurable, achievable, 
realistic and time-bound (SMART) objectives were established to assist in achieving 
the aim of the project. A SMART goal is relevant to a particular aim of an 
organisation and ensures that there will be a measurable and attainable outcome 
(Chamberlin, 2011). 
 
 
1.4.1 Aim 
 
The aim of this project was to introduce an adult sweat test clinic in the OPD of an 
Acute Hospital. 
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1.4.2 Objectives 
 
1. Conduct a review of adult sweat test requests and current paediatric 
appointments by 25th October 2015. 
2. By 20th January 2016, 100% of appropriate clerical staff would be trained on 
the Hospital patient management system (PIMS), used for appointment 
management. 
3. Activity-based funding for each sweat test would be calculated by 14th March 
2016. 
4. From 28th March 2016, an appointment wait time of eight weeks for all new 
adult sweat test referrals would be achieved.  
 
 
1.5 Role of the student in the organisation and project 
 
 As a Senior medical scientist in the Clinical Chemistry Laboratory, the author was 
involved in maintaining the laboratory element of the paediatric sweat test service. 
On completion of this project, it was envisaged that the adult clinic, for patients over 
16 years of age, would be integrated with the paediatric service. The author had a 
key role in communicating effectively with all stakeholders throughout the process. 
The authors’ role in this project included engaging with stakeholders, and developing 
and leading the change. To achieve this a SWOT (strengths, weaknesses, 
opportunities, threats) analysis and stakeholder analysis was carried out during the 
planning phase to identify potential areas of resistance and threats to the 
implementation of the proposal. A force field analysis was also performed. A 
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literature review was completed to investigate access to sweat test clinics where 
there is a suspicion of CF in an adult patient. This evidence was used to help reduce 
resistance encountered during the implementation of the clinic. 
 
As described by Alimo-Metclafe and Alban-Metclafe leadership is firmly at the core of 
the modernisation of the health service (Alimo-Metclafe & Alban-Metclafe, 2006). 
Given the changes and difficulties the Irish health service has faced real opportunity 
exists for leadership at all levels. Rather than followers disconnected from leaders, a 
challenge exists to strengthen the leadership from within, delivering high-quality 
services with limited resources and collectively engaging all members of the 
organisation.  
 
 
1.6 Summary and conclusion 
 
The aim of this OD project was to implement an adult sweat test clinic in the OPD of 
an Acute Hospital. The HSE change model was used to facilitate the process, and 
SMART objectives were set out to ensure the aim would be achieved. The following 
chapters will discuss the evidence for the change, the theory regarding 
organisational change and the OD process, and the evaluation of the SMART 
objectives set in the planning stage of the project. 
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2.0 Literature Review 
 
2.1 Introduction  
 
The purpose of chapter two is to provide a systematic review of the literature around 
the introduction of an adult sweat test clinic. A literature review encompasses a 
literature search utilising appropriate databases, analysis of papers, referencing, 
formulating research proposals and writing thematic reviews of the literature using 
critical analysis (Leger & Sirichand, 2015). Common themes within this literature 
review are then discussed in relation to the OD project, and any implications for the 
project are highlighted. 
 
Worldwide the life expectancy of patients with CF has increased over the last two 
decades (Edwards, Clarke, & Greenop, 2013), which will have implications for 
specialist health services required for CF patients. It is also now widely recognised 
that outcomes for patients cared for in specialist CF Centres are better than for those 
who are not, and the key to the effectiveness of the specialist CF centre is the 
multidisciplinary team (MDT) (Conway et al., 2014). Ensuring timely access to 
services improves the patient experience and outcomes. The quality of patient care 
is predicated on the ability to diagnose and commence treatment as quickly as 
possible (O’Riordan et al. 2013). 
 
The HSE have stated that €97 million of the health budget for 2016 has been 
allocated for specific new service developments while acknowledging the current 
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system lacks the capacity to provide accessible services required to meet current 
population demands (Health Service Executive, 2016). This highlights the difficulties 
faced by many healthcare organisations, the demand for new services and an 
increasing population with no concomitant increase in capacity. The HSE regularly 
reports on waiting times for accessing hospital services. Patient waiting times are 
often used as an indicator of quality within health systems (Olisemeke et al. 2013; 
Lodge & Bamford 2007). Each organisation has a responsibility to manage 
appropriately its services ensuring patients are not waiting excessively to access 
hospital care. 
 
 
2.2 Search Strategy 
 
An initial literature review focused on the requirement for adult sweat test clinics in 
the diagnosis of CF. The following databases were utilised: Embase, Medline (Ovid), 
Google Scholar and Lenus. Funding for Ivacaftor, the treatment for CF patients with 
the G551D genotype which is present in approximately 11.6% of the Irish CF patient 
population, was introduced in 2013. With this in mind, the literature review was date 
limited for each database. Where literature could not be obtained, the timeframe was 
extended. As medical knowledge and expertise advance, the life expectancy for CF 
patients has also increased. Patients who would not have reached adulthood are 
now surviving into middle age, and this has also impacted the number of mild 
variants of CF being identified (Traeger, Shi, & Dozor, 2014). This relatively recent 
advancement also influenced the time span of the review.  The four databases were 
searched using a combination of the following; adult, sweat test, clinic, service, cystic 
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fibrosis, diagnosis in adults. A total of 22 articles from this search were deemed 
relevant to the review. 
 
Upon reading the articles from the search, a second literature review was performed 
focusing on the wider topic of commissioning a service. The articles from the initial 
review were based mainly on the use of the sweat test in the diagnosis of CF. The 
articles written were based on quantitative studies and data, such as the 
performance of the chloride method in relation to the diagnosis of CF. As the life 
expectancy of CF patients has only been increasing in recent years, there is 
relatively little-published material on CF in adults. This is reflected in the initial 
literature review results. The revised literature review focused on the change 
initiative proposal, the commissioning and implementation of a specialised service in 
an acute hospital. Although many of the results were not relevant to CF, they can be 
applied to the development of any specialist service across healthcare. Due to the 
requirements of a patient with CF, it can be defined as a specialist service. The 
databases utilised as part of the literature review were Embase, 
Medline/CINAHL/Health Business Elite, Emerald, Scopus, Web of Science and 
Google Scholar.  
 
 Embase: The Embase database was accessed through the RCSI library on 
07/02/2016. The advanced search option was used to search using the words 
specialist and service, specialist and clinic, commissioning, and adult. The 
search results from specialist and service and specialist and clinic were then 
combined using or. The result of this search was combined with 
commissioning using and. The result of this search was then combined with 
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the result from the adult search using and. The date was limited from 2012 to 
2016. This search provided 24 articles, eleven of which were relevant to the 
project.  
 Medline/CINAHL/Health Business Elite: These three databases were 
accessed together through the RCSI website on 09/01/2016. The search date 
was limited from 2005 to 2016. An advanced search was performed using the 
keywords adult services, specialist services and commissioning services. 
These were then combined using AND which resulted in a search total of 4 
articles.  
 Emerald: The Emerald database was accessed on 09/01/2016. The search 
period applied was from January 2005 to January 2016. The terms 
commissioning and specialist services were searched together using AND. 
The search was limited to articles that had the search terms in their abstracts. 
This gave 58 results, of which 11 were relevant to the review. One article from 
this search was not included as it had been sourced from the Embase search.  
 Scopus: The Scopus database was accessed on 07/02/2016. A search was 
performed using the words commissioning, specialist services, adult and 
hospital, all combined with AND. The search was limited from 2012 to 2016. 
This resulted in 7 articles, 3 of which were relevant to the review.  
 Web of Science: The web of science database was accessed on 07/02/2016. 
A search of commissioning services AND specialist services AND adults gave 
11 results. The date was restricted from 2012 to 2016. Two of these articles 
had been found in the search of the Scopus database. Five of the remaining 
article were relevant for the review.  
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 Google Scholar: An advanced search was performed on Google Scholar on 
07/02/2016. A search with all of the words “commissioning a service in an 
acute hospital”, with the exact phrase “specialist service”, with at least one of 
the words “adult” and without the word “community” was performed for all 
articles from 2012 up to the date of the search. The articles found had the 
selected words occurring anywhere in the text of the article. 29 articles were 
found, of which four were relevant for this literature review. 
 
The literature review yielded 38 articles relevant to the topic. Some references within 
the 38 articles were also reviewed where relevant. Key themes appearing in the 
articles were further explored. Four key themes emerged: developing quality 
indicators, access to services, governance, and engagement. These will be 
discussed in relation to the literature reviewed.  
 
 
2.3 Review of Themes 
 
 
2.3.1 Developing quality indicators 
 
Key performance indicators (KPIs) are an essential tool for monitoring the 
performance of a service. Increasingly they are being used in healthcare to both 
identify where performance is good and meeting standards and to highlight areas 
where improvements are required. KPIs promote accountability within an 
organisation, allowing comparisons with other organisations and also to the stated 
objectives of an organisation (Health Information and Quality Authority, 2013). 
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Commissioning of a new service should be done in compliance with a published 
standard or framework, as described by Goenka, Turner and Vora, to ensure high-
quality care for the service user. They reviewed task force recommendations to help 
assist managers, commissioners and healthcare professionals to provide advice on 
the structure, roles and components of specialist diabetes services for adults 
(Goenka, Turner, & Vora, 2011). Due to the complex nature of healthcare, this can 
be difficult to achieve. However, healthcare professionals have a responsibility to 
ensure high-quality care is provided.  
 
Effective commissioning of a service requires a continual assessment to ensure the 
needs of the service users are being met (“Empowering patients through the 
commissioning of specialist stoma care services,” 2015). This learning is then 
applied to the service to support further improvements in the experience of those 
using and providing it (Rogers, 2013). The criteria these units are measured against 
will also be open to future modifications to reflect the changing directions and needs 
of the service meaning they will have to adopt a continual push to maintain and 
enhance their standards (Poppleton, Turner‐Stokes, Dhillon, & Schoewenaars, 
2012). KPIs provide the foundation for performance measurement and help to 
measure progress against predefined targets or benchmarks, spend more time on 
critical activities, and compare performance across the organisation (Ghazisaeidi et 
al., 2015). 
 
In commissioning a service, roles and responsibilities should be addressed to ensure 
that standards are met to meet commissioning requirements and deliver high-quality 
care to patients (Goenka et al., 2011). Workforce planning, having the right staff with 
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the right skills in the right place at the right time (Department of Health, 2002), is 
integral to service planning and delivery and will be discussed further in chapter 
three.  As we move towards a trend for services to be paid by activity and 
increasingly related to outcome, data collection and measurement against an agreed 
framework or standard is vital to provide evidence of services meeting needs and 
offering the best value for money (Poppleton et al., 2012). Activity based funding 
(ABF), a new model for funding public healthcare, will see providers funded in line 
with activity achieved (Health Service Executive, 2015a). As ABF is introduced and 
hospitals face fines for patients exceeding waiting time targets, KPIs will play a key 
role in ensuring services within an organisation are utilised to their full potential.  
 
Within the clinical chemistry laboratory of the organisation, KPI’s are already in use 
to ensure laboratory services meet specific criteria such as the international 
standards organisation 15189:2012 standard for medical laboratories (International 
Standard ISO 15189 Medical laboratories- Requirements for quality and 
competence, 2012). The adult sweat test service will be commissioned in line with 
these requirements. Turnaround times (TATs) are regularly monitored for all 
laboratory tests as another measure of quality. TATs for the sweat chloride and 
sweat conductivity for all sweat tests, including adults, will be monitored to ensure 
compliance. Insufficient collection rates will also be monitored. These will then feed 
into the KPIs for the service ensuring safe quality care is delivered to the patient. 
Although the laboratory would regularly measure and analyse quality indicators, the 
sweat test service represents a slight variation as the laboratory is involved in issuing 
appointments and monitoring waiting lists. This will require communication with 
clinicians and management outside the laboratory, as well as within the Department, 
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to ensure HSE requirements are met. Engagement will also be required to ensure 
the KPIs measured feedback effectively.   
 
 
2.3.2 Access to services 
 
One way of improving healthcare is by providing innovative access to services by 
reviewing how they are scheduled (Berwick et al., 2008). Chronic disease, the main 
reason people seek healthcare in the developed world, encompasses a set of 
progressive and long-term medical conditions to which countries are now responding 
by seeking to improve services. A qualitative study involving semi-structured 
interviews with 40 nurses in the East of England found that nurse-led prescribing 
enabled nurses to overcome existing problems in service provision to improve 
amongst other things the access and efficiency of a service (Carey, Stenner, & 
Courtenay, 2014). The results of this study demonstrate the positive outcomes when 
a service is restructured based on what is best for the patient or new demands. 
Healthcare delivery is continually changing and to ensure the services required are 
available it is necessary to remain abreast of emerging best practice guidelines and 
policy decisions that may affect service provision. The study also noted concerns 
which were raised including increasing responsibility and the governance of the 
service. These are important elements in the delivery of any service to ensure 
patients receive safe, quality care. 
 
Improving access can improve patient satisfaction rates (Carey et al., 2014). Part of 
the mission of the HSE National Service Plan 2016 is that patients in Ireland can 
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access safe, compassionate and quality care when they need it, with one of the 
goals being fair, equitable and timely access to services (Health Service Executive, 
2016). Patients rate access to appropriate networks and services as one of the most 
important aspects of care (Burns, Silberman, & McCann, 2010). Although this study 
looked at long-term access and continuity of care for patients with a long-term 
neurological disorder, the access they required was similar to that of other patients 
with a long-term illness. A study evaluating the effectiveness of a specialist nursing 
service for adult patients with congenital heart disease was conducted over two 
years using postal questionnaires. Statistical analysis on the quantitative data 
identified priority areas such as specialist knowledge and expertise, and accessibility 
was a dominant topic amongst respondents (Hatchett, McLaren, Corrigan, & Filer, 
2015). The participants in this study had already received access to specialist care, 
which may affect the satisfaction rating of the responses. Gaining access to 
specialist services is often seen as the stumbling block in healthcare. In a study 
using a mix of methods to assess progress towards national service 
improvement for long-term neurology care, organisational restructuring, limited 
finances and competing policies had hampered progress and were barriers to 
implementation of services (Gridley, Aspinal, Bernard, & Parker, 2011).  
 
While advances in treatment have improved the survival age for CF patients, the risk 
and consequence of infection remains high, resulting in strict infection control 
protocols for CF patients attending hospitals. Isolation units are often required for 
these patients, resulting in access issues where a large number of CF patients are 
attending a particular unit. The CF community wishes to ensure standards of care 
and equal access to specialist services for all patients (Cystic Fibrosis Trust, 2011). 
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The demand placed on healthcare services due to a growing population and an 
increase in the number of people living with a long-term illness can adversely affect 
accessibility to these services. Each hospital must be responsible for ensuring they 
provide the right service to the right patient at the right time.  
 
In Ireland 48 acute hospitals provide a broad range of inpatient and outpatient 
services to a population of almost 4.6 million (“Acute Hospital Division Operational 
Plan 2015,” 2014). Funding is an essential consideration when commissioning 
services (Burns et al., 2010). There is often a conflict in healthcare where the cost of 
providing high quality, best practice healthcare is rising each year, and the demand 
for these services is also increasing. Daidone and Street looked at applying empirical 
hospital costing approach, a model of costing which builds on patient-level data, to 
determine the additional cost to hospitals that delivered specialist care. Analysing 
costs for over 12 million patients in 163 English hospitals, they found that, for 
nineteen types of specialised care, patients did not have higher costs than other 
patients allocated to the same cost group. However, costs were higher if a patient 
had cancer, spinal, neurosciences, cystic fibrosis, children’s, rheumatology, 
colorectal or orthopaedic specialised services (Daidone & Street, 2013). Access to 
specialist services in hospitals may be difficult if a hospital is not subsidised or in 
receipt of additional funding to provide these services.  
 
Strategic planning is vital to meet the future challenges in healthcare (Hatchett et al., 
2015). A large population-based study investigating the use of psychiatric services in 
adults with intellectual disability found that less than 50% accessed the services 
(Bhaumik, Tyrer, McGrother, & Ganghadaran, 2008). The study resulted from 
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concerns over access to services for these adults and the results highlight the need 
to ensure services are accessible to those for whom they are intended.   
 
 
2.3.3 Governance  
 
Clinical governance, a system within an organisation that ensures procedures are in 
place to provide continuous improvement, provides the opportunity to understand 
and develop the fundamental components required to facilitate the delivery of quality 
care (Halligan, 2001). It is the central element of a framework that supports the 
delivery of quality. The introduction of clinical governance as a means to drive up the 
quality of health care required action at all levels within organisations (Rogers, 
2013), who discussed the successful implementation of a clinical governance 
development programme to educate national health service (NHS) staff. A national 
drive to promote clinical governance and enter it into local systems and processes 
was the trigger, focusing on a bottom-up approach, acknowledging the many 
successful service initiatives that happen at the local level. Although clinical 
governance was deemed to be successfully implemented, the study mentions the 
low number of participants relative to the size of the NHS workforce (Rogers, 2013). 
This highlights the difficulty of introducing any new service. While many successful 
services are provided at the local level, there can be difficulty communicating these 
changes across the health service, thus compromising the sustainability of the 
initiative. While the study acknowledged the positive changes happening at the local 
level, due to the complexity of the health service, support is often required at a senior 
level to ensure a service is maintained.  
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Clinical governance was introduced to ensure healthcare was provided in a patient 
centred way and that the commitment to high-quality care was the focus of everyday 
practice (Scally & Donaldson, 1998). Results from studies investigating the effect of 
clinical governance programmes suggest that effective working by health 
professionals, using the principles of clinical governance, can improve care for 
patients (Jenkinson, 2006). While this study looked specifically at the effect of a 
clinical governance programme on stroke services, it could be applied to other areas 
of healthcare. Clinical governance is designed to promote good practice, and a key 
feature of it is to monitor and improve professional performance (Brennan & Flynn, 
2013). For governance to be effective, there must be a desire to refocus efforts and 
energies ensuring maximum penetration of services. An all too common experience 
reported by consumers and carers is for a person to get lost somewhere between 
the hospital discharge and the primary care provider, or between the employment 
support services and the housing provider (Rosenberg, 2012). 
 
The introduction of clinical governance structures is in part due to declining 
standards in the provision of healthcare. Other contributing factors include changes 
in health policy and changes in the delivery of healthcare (McSherry & Pearce, 
2011). Improvements in service provision are always welcomed and any service 
being commissioned should have clinical governance to the fore ensuring the best 
possible care and outcomes for all who avail of it. An audit of specialist inpatient 
services documenting deficient care standards and lacking person centred planning 
indicated that these services were lacking clinical governance (Barron, Robotham, & 
Hassiotis, 2008). Recommendations were similar to principles set out in the 
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European Convention on Human Rights, and reiterate the importance of 
mechanisms incorporated within clinical governance such as communication with the 
patient and education and training. 
 
Reform is fundamental to service improvement and a priority for those seeking to 
improve the experiences of patients and staff (Rogers, 2013). The need for a role in 
feedback mechanisms, research and promoting evidence-based practice 
(Rosenberg, 2012) is seen as an important function of any governance structure. In 
this community-based study to determine the main concerns of service providers and 
service users key themes emerged; funding, consultation and resource monitoring. 
These concerns should be to the fore where governance structures are introduced 
with the aim of improving a service and making it more effective.  To ensure best 
practice commissioners and funders of such services ensure information is gathered 
and provided relating to evidencing and meeting needs (Rogers, 2013). 
 
 
2.3.4 Engagement 
 
Engagement is classified as a positive, fulfilling, work-related state of mind, 
characterised by vigour and dedication (Schaufeli, Salanova, González-Romá, & 
Bakker, 2002). Engagement involves listening to people and recognising what is 
needed to motivate and encourage them. Individuals seek to experience meaningful 
work that maximises their sense of motivation (Yasin Ghadi, Fernando, & Caputi, 
2013). In 2014, the first ever health sector-wide survey was conducted by the HSE to 
provide an accurate measure and reflection of employee sentiment and 
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engagement. With a response rate of 7.1%, the low survey completion rate was in 
itself a measure of engagement within the workforce at the time (Ipsos MRBI, 2015). 
An engaged workforce within healthcare is important to ensure patients benefit from 
the best care possible when they require it. Organisations also have a responsibility 
to their staff to ensure they create a working environment suitable to meet demands. 
This will be discussed further in chapter three with the concept of ethical leadership. 
Responding to the survey outcome, the HSE development a staff engagement 
improvement plan. 
 
Healthcare organisations will not be fully effective if departments continue to work in 
silos, which characterise traditional approaches to health care (Rosenberg, 2012). 
An integrated approach and joined up services are required, one that promotes 
engagement with service users and service providers. This is especially true for 
patients requiring input from multiple specialities within healthcare. For patients to 
have confidence and trust in the care provided, all carers must communicate to 
ensure the patients’ needs are met. Leadership and successful collaboration and 
cross-boundary working are among the key factors thought to enhance transitional 
care between services (Ogundele, 2013). When an integrated approach was used 
staff reported benefits regarding their own personal and professional development, 
local team working and, importantly, in respect of the services in which they work 
(Rogers, 2013). A patient-nurse collaboration and a drive to improve the delivery of 
fit-for-purpose stoma care services that are safe, effective, patient-centred, 
equitable, and easily accessible have resulted in delivering what patients want rather 
than what service providers think they need (“Empowering patients through the 
commissioning of specialist stoma care services,” 2015). This initiative helped stoma 
33 
 
care patients in the community, reducing the burden on local hospitals. It is an 
example of specialist services coming together to provide best practice care for the 
patient, who has also been involved the planning.  
 
Patients with long-term conditions require support from a range of services and 
professionals but often find these do not work in a joined up way (Gridley et al., 
2011). This paper used three different methodologies to assess the provision of 
integrated services for people with long-term neurological conditions. These patients 
require input from multiple specialities, similar to the requirements of a CF patient. 
However, there is little-published data on the cost-effectiveness of these services 
(Gridley et al., 2011). Outcome measures may be related to clinical outcomes, 
outcomes relating to patient quality of life or experience may provide more 
information.  
 
One finding of a study looking at the effect of a clinical governance programme was 
it engaged over half of NHS organisations and reaching a “tipping point” of 
momentum across the NHS (Rogers, 2013). Staff engagement also had a positive 
effect on the patients and service users. Engagement across services is important 
for the effective management of specialist care services such as CF. The driver for 
this organisational development project was the lack of access to sweat test clinics 
for adult patients. As CF is an illness that is more likely to be diagnosed in childhood, 
and with no effective treatment available, the demand for an adult service was low. 
The introduction of Ivacaftor and the recognition of milder CF phenotypes in adults 
(Woods, 2013) has increased demand. The importance of engagement with all 
service providers is evident in the HSE reimbursement protocol for Ivacaftor, which 
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states that all patients must have an annual sweat test. As these patients would not 
have previously required regular sweat testing, and with a large number of these 
patients under the care of specialist adult CF hospitals, they had no access to a 
sweat test service.  Current sweat test clinic providers had received no prior 
notification of the potential increase in clinic demand. This demonstrates the complex 
nature of healthcare, the requirement for effective communication and the difficulties 
in engaging with all service providers.  
 
 
2.4 Implications for the project  
 
The above literature review provides a broad overview of current practice in 
commissioning services within healthcare. Publications on accessing services and 
the requirement of high-quality care are abundant. No standard or guideline exists 
for commissioning a new healthcare service in Ireland. Frameworks for particular 
healthcare services have been developed by the National Health Service (NHS) in 
England. Commissioning a service relies on active involvement from all individuals 
involved. In a complex system sure as healthcare, this can be a challenge. At a time 
when budgets are closely monitored, and the cost of healthcare continues to rise, 
any potential cost increases for an organisation could impact on service 
development.  The focus of this organisational development project is to ensure 
those patients that require a sweat test will have access to the service promptly, 
restructuring the current service to meet these changing service demands. 
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2.5 Summary and Conclusion 
 
This chapter reviewed literature on commissioning a specialist service, an adult 
sweat test clinic. Access to services and provision of quality care are important 
issues in any healthcare system. Long wait times may impact on a patients’ quality of 
life. As service requirements change, healthcare organisations must adapt, 
maximising the capacity within their organisations, allowing service users to access 
appropriate care when needed. The key to this is engagement and communication 
between all heath care providers and the HSE, ensuring patient centred care is 
available to those for whom it is intended. 
 
 
3.0 Organisational Development Process 
 
3.1 Introduction 
 
OD is directed at bringing about planned change to increase an organisation’s 
effectiveness (Cummings & Worley, 2014). Healthcare services undergo continuous 
change and transformation in response to the needs and expectations of service 
users, and legal obligations to meet standards of quality and care. Change is an 
adaptive process, and organisational change is also dependent on people changing 
(Improving our services: A user’s guide to managing change in the Health Service 
Executive, 2008). Making change happen can test a leader in terms of resolve, 
emotions and belief. As described by Kotter, leadership is about coping with change 
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(Kotter, 1999) and effective leadership facilitates change by supporting and 
motivating those most affected by the change to embrace it. This chapter will discuss 
the application of the HSE change model as a framework for the implementation of 
organisational change, an adult sweat test service.  
 
Although barriers may stand in the way of inducing change in healthcare 
organisations, several factors can foster its continuation and help in making it 
succeed such as having strong leadership, concentrating on patient safety 
and focusing on improving the level of care (National Institute for Health and Clinical 
Excellence, 2007). For change to be successful takes time, and the planning and 
implementation of change is a key challenge for all leaders. Early research on the 
effectiveness of change showed that 50% of all efforts fail (Kotter, 1995). Recent 
studies claim the failure rate is closer to 75% (Erwin & Garman, 2010; Higgs & 
Rowland, 2000). The application of a practical change model along with effective 
leadership from those involved in the change can help in its success.  
 
 
3.2 Critical review of approaches to organisational development 
 
OD is described as a systematic application and transfer of behavioural science to 
the planned development and improvement of processes that lead to organisational 
effectiveness (Cummings & Worley, 2014). The OD approach is above all an 
approach that cares about people and has people within organisations at the centre 
of change (Senior & Swailes, 2010). As healthcare organisations are complex 
systems lasting and effective change can be difficult to achieve. OD operates at all 
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levels of an organisation and is a relatively long-term process. Change may take five 
to ten years to sink deeply into the culture of an organisation (Kotter, 1995), 
highlighting the complexity of any planned change.   
  
Kurt Lewin is considered to be the founding father of OD (Burnes, 2004). Lewin’s 
three stage model for change is probably the most widely known change model 
(Cummings & Worley, 2014) and his work created the basis of the OD approach to 
change. The three phases are unfreezing, moving and refreezing. Unfreezing, the 
first phase, refers to disturbing the status quo to heighten people’s awareness of the 
need for change. The moving phase involves making the change that will move the 
organisation into a new state. Refreezing, the final phase of the process involves 
stabilising the changes. This model, while simplistic, may be criticised for the 
concept of refreezing, which implies that once a change is made it is held that way 
until there is a need to change again. In reality, modern organisations operate in a 
continuous cycle of change. Lewins three stage model has also be criticised as 
suitable only for small scale projects, ignoring organisational power and politics and 
being top-down driven. However, the three-stage model of change was part of 
Lewins broader work in helping to understand individual and group behaviour, and 
their role in organisations and society which is still relevant today (Burnes, 2004). 
 
Lewins research on change, along with organisational studies by Coch and French 
(Coch & French, 1948) has also played an important role in understanding the 
organisational context of resistance to change, which will be discussed later in this 
chapter. Further OD models have since been described, one of which is the 
Cummings and Worley six phase model for change (Cummings & Worley, 2014). OD 
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approaches to change assume that groups are an essential element of a change 
process, oriented towards improving the organisation as a whole. OD can, therefore, 
be viewed as a process that facilitates change, helping an organisation move 
through the phases of change, taking the organisation from its current status to a 
new state.  
 
Situations in which change arises vary in complexity. The terms ‘hard’ and ‘soft’ are 
used to describe these complex problems (Paton & McCalman, 2000). Change 
management involves soft issues such as culture, leadership and motivation. These 
elements are important to the success of planned change, but managing these 
aspects alone is not sufficient to implement transformation projects.  Companies also 
need to consider the hard factors, like the time it takes to complete a change 
initiative and the number of people required to execute it (Sirkin, Keenan, & Jackson, 
2005). Change in situations that show soft complexity, where issues are contentious 
and there is a high level of emotional involvement from those affected by the change, 
generally take longer than changes of hard complexity, based on a systematic 
approach to change (Senior & Swailes, 2010). A change model is a useful tool in 
helping to guide and understand the change process and change management. The 
implementation of an adult sweat test clinic can be described as a soft issue as it 
involves many different stakeholders from various departments within the 
organisation. As the sweat test is used in the diagnosis of CF, there is also a high 
level of emotional involvement from both clinicians and patients waiting on sweat test 
appointments. There is also a degree of emotional involvement from staff directly 
affected by the change who on one hand are aware of the benefits to patients 
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requiring access to a sweat test service, and on the other hand whose rosters are 
being directly affected by the introduction of a Friday morning clinic.  
 
The Senior and Swailes model for OD recognises that some systems, including 
health care, require a soft systems approach to change (Senior & Swailes, 2010). It 
builds on the action research approach instigated by Lewin, recognising that change 
is not a one-off event and that all who are or who might be involved in any change 
are part of the decision-making process. This is in keeping with the work by Coch 
and French in which they demonstrated that the degree of staff participation in a 
planned change was inversely related to the level of resistance to that change (Coch 
& French, 1948). It does not assume that others will automatically accept a project 
implemented by senior managers in the organisation. Leading on from the concept of 
action research, it recognises the effect of an organisations internal and external 
factors in the success of an OD project. This model for change puts the change 
agent at the centre of the process, recognising the role of the facilitator when guiding 
an OD plan. Similar to the HSE change model, it emphasises the importance of the 
planning stage, ensuring sufficient data is gathered to understand and plan the 
change. Each of these OD models represents the reality of change in organisations. 
Change is a fluid, dynamic process and a planned change does not smoothly move 
from one step to the next.  
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3.3 Rationale for OD model selected 
 
The HSE change model has been developed to promote a consistent approach to 
change, helping staff to improve services thereby improving the experience of 
service users (Improving our services: A user’s guide to managing change in the 
Health Service Executive, 2008). The HSE change model is based on four phases of 
change, initiation, planning, implementation and mainstreaming. Similar to the NHS 
model for change (NHS, 2013), the HSE change model places particular emphasis 
on the people and cultural aspects of change. This model is more flexible than the 
step by step guide of linear models for change, such as Kotter’s eight step change 
model. Kotter’s model, when first published in 1995 (Kotter, 1995), differed from 
other models of change management in that it was not evidence-based and did not 
reference any outside sources (Appelbaum, Habashy, Malo, & Shafiq, 2012). The 
HSE change model recognises that change is a constant state of flux, and each of 
the four phases is linked to the other, reflecting the complexity of the healthcare 
service as a whole. This model also recognises the important role of people both in 
the change process itself and in sustaining change, with a focus on encouraging 
communication, support and development. 
 
As discussed in chapter two, engagement levels within the healthcare service were 
measured in a 2014 HSE staff survey (Ipsos MRBI, 2015). Many factors could be 
considered to affect current sentiment within healthcare. At an organisational wide 
level recruitment embargos, staff shortages and increasing activity all impact on the 
staff morale. Within the laboratory, implementation of the 8 am to 8 pm extended 
working day, the discussion around hot and cold laboratories, and the introduction of 
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blood sciences core laboratories has created uncertainty. With employees being 
exposed to ever increasing changes, it is important that any planned change 
introduced would be done in a manner that minimises anxiety for all those affected 
by it. The HSE model places a strong focus on the people aspects of change, of 
which, as previously mentioned there are many examples in this OD process.  
 
The vision of the HSE is that everybody will have access to high-quality care and 
services (Health Service Executive, 2015b) which underpins the HSE change model. 
As the focus of this OD project is the introduction of a sweat test clinic for adults, 
which is essentially about providing access to services in an acute hospital, the HSE 
change model has been selected as a framework to guide the change. The user 
guide is based on a comprehensive literature review of best practice and 
organisational experience of what works (Improving our services: A user’s guide to 
managing change in the Health Service Executive, 2008) also recognising the role of 
leadership in guiding change and the influence leaders have on the success of OD.  
 
 
3.4 HSE change model 
 
3.4.1 Initiation 
 
The purpose of the early preparation and scoping stage is to create readiness and a 
considered case for change, to establish a sense of shared responsibility, and to 
scope out a solid foundation for successful change (Improving our services: A user’s 
guide to managing change in the Health Service Executive, 2008). The initiation 
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phase of the model (figure 1) involves outlining the objectives of the change 
proposal. The need for change is identified and the organisations readiness for 
change is assessed. The catalyst for this OD process was an increase in the 
demand for adult sweat test appointments. Referral letters were sent to the 
Laboratory as the organisation was already a designated centre for CF new-born 
screening. As the Laboratory had received these referrals, there was a responsibility 
to respond to the requests. A decision was made to initiate development of an adult 
sweat test clinic and the change agent was given the task of leading the project. 
Support was required from the Consultant Chemical Pathologist, the Chief Medical 
Scientist in Clinical Chemistry and the Laboratory Manager to ensure the initiative 
would gain the required momentum to proceed. The referral requests were then 
placed on the organisations waiting list management system until the clinic was 
implemented. Ethical approval was sought from the organisations ethics committee 
at this stage. 
 
Figure 1: HSE change model 
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A SWOT analysis (Appendix 1) was performed and key stakeholders (Appendix 2) 
were identified to ensure the change would be communicated to all those affected by 
it. A force field analysis was completed (Appendix 3) to identify the forces impacting 
on the proposed change. The focus on identifying key stakeholders is essential as 
particularly in healthcare; no service operates in isolation and change in one part of 
the organisation can impact in different ways and at different levels (Improving our 
services: A user’s guide to managing change in the Health Service Executive, 2008). 
Mapping out key individuals at this early stage can help identify areas of concern for 
all groups. Once key stakeholders were identified, the organisations readiness for 
change was then determined and the planned OD project was communicated to all 
in formal and informal face to face meetings. Concerns regarding the proposed 
change and any potential resistance was acknowledged. While resistance was low at 
this stage of the change initiative, it will be discussed further during the 
implementation phase, as due to unexpected factors resistance arose later in the 
project. This highlighted the importance of communication in a change project and 
the role of the change agent in communicating to all stakeholders, which as 
discussed in the reflective piece cannot be over-emphasised when carrying out an 
OD project. Change agents may contribute to the occurrence of resistance by 
ineffective communication (Ford, Ford, & D’Amelio, 2008; Kotter, 1995). 
 
Organisational politics was also considered at this stage of the change process. 
Political astuteness, defined in the NHS Leadership Framework as being able to 
interpret the likely changes in the health service and beyond (NHS Leadership 
Qualities Framework, 2002) is a key element of leading change in any organisation. 
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The need for change facilitators to be politically astute is also recognised in the Irish 
health system. Support from formal hierarchical organisational structures may not 
ensure the success of the change (McAuliffe & VanVaerenbergh, 2006). Politically 
astute change facilitators’ work to build commitment by establishing informal 
networks with those interested in the change succeeding. This then helps to reduce 
the effect of the resistant forces. The paediatric sweat test clinic is held in a 
designated room in the paediatric OPD. The analysis equipment for sweat chloride 
and conductivity is also kept in this room, enabling the medical scientist to carry out 
sweat collection and analysis in one setting. As this area was not suitable to run an 
adult clinic, an alternative location was sought. The adult OPD  was not deemed 
suitable as space is an issue due to the number of clinics already running in the 
area. Enquiries were made into the possibility of obtaining a room one morning a 
week in the adult out-patient setting. Although there is an application process for 
requesting a room, due to the high volume of clinics applications may not be granted. 
At this stage, it was decided that the clinic would move to the endocrinology facility. 
Although this would mean the scientist performing the sweat test would need to 
move to the paediatric sweat test room to perform the analysis, it was felt that 
delaying the OD process to wait for a room closer to the current paediatric location 
would hinder the project. The Consultant Chemical Pathologist also ran a clinic in the 
Endocrinology Department on Friday mornings enabling the sweat test clinic to have 
appropriate consultant cover. As the patients had been placed on the hospital 
waiting list, any delay in implementing the sweat test clinic would increase the 
waiting time which could ultimately have financial implications for the organisation 
(Health Service Executive, 2013). The potential financial impact of the waiting lists 
was only realised later in the change project, and again highlighted the importance of 
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communication at all levels within an organisation. This OD project was the first time 
the Clinical Chemistry Laboratory was involved with waiting list management, and as 
such was the first exposure to potential fines for patients exceeding HSE wait times. 
The learning from this is further discussed in the reflective pieces.  
 
The need for additional resources, other than an alternative location for the adult 
clinic, was considered but not required. The would be no net increase in sweat test 
clinics as the adult clinics would be held on alternate Fridays and the paediatric clinic 
would be reduced to every second Tuesday. This was agreed with the Consultant 
Chemical Pathologist and Chief Medical Scientist, with any potential increase in the 
paediatric requests being monitored to ensure that clinic was not negatively 
impacted by the change. It was agreed that the impact of a Friday morning clinic on 
the laboratory would be monitored and discussed should any issues arise.  
 
 
3.4.1.2 Leading change 
 
Change, by definition, requires creating a new system, which in turns demands 
leadership for guidance (Kotter, 1999). The initiation phase of the HSE change 
model focuses on identifying leadership roles and responsibilities to guide the 
change. The style of leadership surrounding the change can influence the success of 
the OD project. Leadership is associated with setting direction, aligning people and 
coping with rapid changes. One function of a leader during change is to concentrate 
on relationships within the organisation that will help them to cope with chaotic 
change (Improving our services: A user’s guide to managing change in the Health 
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Service Executive, 2008). Strong leadership can foster an environment that is 
conducive to change, motivating staff with a desire for continuous improvement 
(National Institute for Health and Clinical Excellence, 2007). Communication is an 
important aspect of any change project and ultimately it is the responsibility of the 
change agent or leader of the change to ensure open and effective communication 
at all stages of an OD process (Armenakis & Harris, 2009; Coch & French, 1948; 
Kotter, 1995).  
 
Just as there are many different approaches to change, there are equally different 
styles for leading change. Rather than one leadership style being effective for 
change to succeed, perhaps more important is the substance, the core behaviour of 
the leader (Kotter, 1999). Change processes often involve turmoil and for those 
directly affected by the change looking for reassurance from an authentic leader may 
be the stabilising factor that is required to ensure the success of the change. Clear 
vision, strategy and direction are all required by leaders and the key to effective 
leadership is having the awareness to communicate these, engaging followers in the 
change process. Leading change is a complex process and the skill may not always 
to be a transformational leader (Senior & Swailes, 2010) but to use ones’ emotional 
intelligence (EQ) for assessing each situation. Self-awareness as a leader and 
change agent is important when progressing an OD project, particularly where there 
is involvement from numerous levels and departments within an organisation. 
Historically healthcare organisations and departments worked in silos and as this is 
changing in favour of a partnership and team working approach, leaders must be 
aware of potential issues that may arise. Necessary supports may be required for 
those going through the change process. Where there is cross-departmental 
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participation within a change project, leaders should also be aware of the cultural 
aspects of change and their impact on the success of the change.  To sustain 
change over the long-term the cultural and the people aspects of change must be 
addressed (Schein, 1984). This includes addressing deeply embedded traditions and 
practices through an inclusive partnership process (Improving our services: A user’s 
guide to managing change in the Health Service Executive, 2008). 
 
Goleman, who examined the relationship between EQ and effective leadership, 
discovered that EQ is necessary for effective leadership (Goleman, 2011). Just as 
leadership and leading change is a continual learning process, so too the skills of EQ 
can be developed over time. Effective leaders take responsibility for decision making 
and communication (Drucker, 2011). This is an important element to the change 
process as leadership also requires taking ownership and responsibility during 
difficult times of change. The theory of ethical leadership argues that we need to 
highlight the importance of promoting the ethical dimension of change as a means of 
ensuring that leaders and their followers act in the interests of the many rather than 
the few (By, Burnes, & Oswick, 2012). Decisions must also be made throughout the 
change process to ensure the change moves in the right direction. These decisions 
may impact those affected by the change. However, they should be made by leaders 
whose moral compass is aligned with that of the organisation. Ethical leaders are 
characterised as having high levels of integrity, setting ethical standards, making 
ethical decisions, and being caring (Cheng, Chang, Kuo, & Cheung, 2014).       
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3.4.2 Planning 
 
The second step of the HSE change model is the planning phase. This emphasises 
building commitment, determining the detail of the change and developing an 
implementation plan. The purpose of this step is to increase further commitment for 
the change across the system while building a shared sense of the vision for change 
and engaging in activities that increase readiness and capacity to embrace new 
requirements (Improving our services: A user’s guide to managing change in the 
Health Service Executive, 2008). As previously discussed, an understanding of the 
culture of an organisation is critical to the success of a change project. The culture 
within the Laboratory would be one of continuous quality improvement. Working 
group recommendations, development of new diagnostic tests and best practise 
guidelines ensure that the Laboratory is continuously changing and improving to 
meet quality requirements. This is reflected in the culture of the wider organisation 
which has always been viewed as a learning organisation. This culture has 
influenced the implementation of this change initiative. As staff within the Laboratory 
were aware of the significance of a CF diagnosis, the need for the change initiative 
was clear which also aided in building a commitment to change. The benefit of the 
clinic was further demonstrated when two previously undiagnosed adult patients had 
positive sweat tests, indicative of CF, heightening employee commitment. 
 
The importance of effective communication is again mentioned in step 2 of the 
change model. Key stakeholders should be continuously informed of updates and 
progress. The value of continuous communication cannot be overstated and as 
discussed in the reflective pieces was one of the poignant discoveries throughout the 
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change project. During the planning phase of the project, the proposed 
implementation plan was discussed with the Chief Medical Scientist and Consultant 
Chemical Pathologist. It had been proposed that the adult waiting list would be 
validated at this stage to ensure that all patients on the list still required an 
appointment. At the planning phase of the project, 33 adults were waiting on a sweat 
test appointment. As the contact details for every patient were not given on the 
referral forms it was not possible to contact each patient. The paediatric clinic had 
been reduced to every second Tuesday at this stage in anticipation of the adult 
Friday clinics being implemented. The clerical officers in the Clinical Chemistry 
Department were responsible for scheduling the paediatric sweat test appointments 
and it was envisaged that they would schedule the adult appointments also. This 
involved additional training in waiting list management on the hospital PIMS. 
Communication was also required with the hospital PIMS administrator to ensure 
adult appointments could be recorded on the system. A template for adult sweat 
tests was drawn up by the clerical officer in conjunction with the change agent, and 
appointment dates were identified and scheduled. Training of clerical staff will be 
further discussed in the evaluation phase of the change as it was one of the 
objectives of the project. 
 
Establishing clear communication pathways and trust between healthcare providers 
is fundamental when carrying out an OD process. Trust drives sustainable 
engagement and engagement drives business performance (Wright, 2015). 
Communication had been initiated with an external hospital regarding their requests 
for sweat tests during the change project. Patients from an external hospital had 
been placed on the organisations waiting list where the sweat test was to be 
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performed. Difficulties establishing effective communication with the external hospital 
resulted in patient waiting times coming close to the threshold allowed. As these 
patients had CF, they required grouping at clinic based on the micro-organisms they 
carry. This had been discussed with the external hospital during the initiation phase 
of the project. It was important to establish clear lines of communication at this satge 
to ensure the CF patients were grouped correctly. 
 
 
3.4.3 Implementation 
 
The implementation phase of the HSE change model focuses on implementing and 
monitoring the intended change to ensure it is meeting its purpose (Improving our 
services: A user’s guide to managing change in the Health Service Executive, 2008). 
Changes in structure, work processes and approaches to service delivery should be 
evident during this phase. The role of the change agent at implementation is to build 
upon partnerships already developed to ensure the change will have long-term 
sustainability. Any challenges encountered are acknowledged and resolved. As 
many issues and the impact of the change may only become evident during 
implementation, the role of a leader in guiding change can be described as not 
necessarily having the ability to foresee every problem, but to have the ability to deal 
with issues as they arise. Acknowledging the personal challenges associated with 
change may help in gaining support from staff as they work through the change.  
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3.4.3.1 Workforce Planning 
 
Staff engagement is required for workforce planning. Workforce planning describes 
the process of determining the right number, mix and distribution of the skills, 
competencies and capabilities for an organisation to deliver evidence-based 
healthcare (Department of Health and Children, 2009). Workforce planning, if 
performed as intended, will play a major role in ensuring the services provided are as 
effective and safe as is possible. It assists organisations in planning for their current 
and future staffing needs (Department of Health and Children, 2009). While the focus 
should be on ensuring high-quality care and outcomes for the patient’s undergoing 
treatment, for the service to be sustainable there is an onus on professionals within 
the organisation to ensure maximum efficiency, creating the most effective use of the 
highly skilled personnel. Workforce planning has to target a long enough time 
horizon if it is to be useful and applicable and has to be done pre-emptively (Lopes, 
Almeida, & Almada-Lobo, 2015). 
 
Workforce planning had been considered at the initiation phase of this OD process 
and had been mentioned when reviewing the literature. However, as the total clinic 
numbers were not increasing there was no net increase in demand for medical 
scientists to perform the sweat testing. Due to unforeseen circumstances, the 
implementation phase of the project coincided with a reduction in staff numbers on 
the rota from eight to five. The adult clinic was implemented at a time of flux within 
the clinical chemistry Department as the Department had also been reduced by four 
whole time equivalents (wte’s). The Department operates an 8 am to 8 pm routine 
service, and also provides a 24/7 emergency on-call service. Reduction in staff 
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numbers placed additional pressures on staff maintaining the rotas. These factors 
contributed to resistance to the introduction of the clinic at the implementation phase.  
 
 
3.4.3.2 Resistance 
 
The role of a leader during change is to work on reducing the resistance by 
recognising the barriers and concerns to the change. The relationship between 
leader and follower can be enhanced by establishing communication and a 
willingness to listen to concerns. Potential resistance may be reduced by creating a 
culture of readiness for change. Resistance can be a valuable resource in 
accomplishing change (Ford & Ford, 2010) and should be viewed positively.  It is a 
form of feedback and can be used constructively to enhance the change process 
(Senior & Swailes, 2010). Responding negatively to resistance can cost good will 
and valuable relationships as well as the opportunity to learn how to improve change 
implementation (Ford & Ford, 2010). Research by Coch and French and Kurt Lewin 
found that resistance did not come from an individual level but rather was as a result 
of the organisational context in which the change occurred (Burnes, 2004; Coch & 
French, 1948).  The resistance described in this change project can be viewed as 
coming from an organisational context. Changes in roster numbers resulted in 
increased demand on staff available. Change can create anxiety and leaders must 
be aware of recognising these symptoms as the occur. EQ and leadership, as 
previously discussed, are important in responding to and reducing resistance 
(Appelbaum, Degbe, MacDonald, & Nguyen-Quang, 2015; Appelbaum, Degbe, 
MacDonald, & NGUYEN-QUANG, 2015; Ford et al., 2008).  
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3.4.4 Mainstreaming   
  
The purpose of mainstreaming is to focus attention on the success of the change 
effort and on integrating and sustaining the new ways of working and behaving 
(Improving our services: A user’s guide to managing change in the Health Service 
Executive, 2008). The mainstreaming phase also looks at evaluation and ways of 
improving the new service. The adult sweat test clinic was successfully implemented 
in the Department. The appointment service was delivered by the laboratory clerical 
officers in conjunction with the paediatric clinic. The evaluation of this OD project will 
be discussed in detail in chapter four. It is important that the role and support of 
stakeholders and those who helped in achieving the aim of the change are 
acknowledged at this stage. Without involvement from others, true change may not 
take place. Building strong collaborative relationships with key stakeholders including 
continuous consultation and participation resulted in ownership, partnership and 
commitment to the change. Acknowledging the success and achievement of staff 
involved in the change creates a positive working environment and readiness for the 
next challenge. Communication and leadership should not be forgotten at this stage 
as new relationships can be strengthened and the new way of doing things becomes 
embedded into routine practice.  
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3.5 Summary and conclusion 
 
Chapter three discussed the implementation of a planned OD project using the HSE 
change model as a framework to guide the change. It facilitated delivery of the aim of 
the project, the introduction of an adult sweat test clinic. It demonstrates the 
usefulness of a dedicated change model when introducing a change initiative, 
emphasising the importance of the initiation and planning stages. A structured model 
when implementing change highlights important factors influencing successful 
change such as organisational culture, communication, resistance, and leadership. 
 
 
4.0 Evaluation 
 
4.1 Introduction 
 
Evaluation is one of the ways in which an organisation can learn (Improving our 
services: A user’s guide to managing change in the Health Service Executive, 2008). 
Flexibility and openness to change are crucial in healthcare, enabling organisations 
to learn and be responsive to communities and service users, making change part of 
the normal way of doing business.  It is important to use evaluation models to identify 
improvements that work well before their wide-spread replication (Parry, Carson-
Stevens, Luff, McPherson, & Goldmann, 2013). Evaluation should be built into any 
change initiative as it provides feedback for all those involved in the change. 
Because improvement initiatives are complex and context sensitive, fixed-protocol 
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randomized controlled trials (the gold standard for evidence-based medicine) are not 
well suited for the evaluation of improvement initiatives (Parry et al., 2013). This 
chapter discusses the importance of evaluation in healthcare. It also examines 
evaluation in relation to the aims and specific, measurable, achievable, realistic and 
time-bound (SMART) objectives stated in chapter one of the OD project using the 
context, input, process, and product (CIPP) model as the evaluation tool. Setting 
SMART objectives at the outset is important as the information gathered from the 
objectives can form the case for change (Improving our services: A user’s guide to 
managing change in the Health Service Executive, 2008).  
 
 
4.2 Significance of Healthcare Evaluation 
 
Evaluation is a key component of healthcare. Managers and policy makers must 
ensure resources are used to their best effect and answer questions as to why 
particular decisions have been made on the public’s behalf (Øvretveit, 2002). 
Questions may be why a screening programme has been aimed at a particular 
gender or age group, or why funding has not been made available to a particular 
group of patients. In relation to CF, these questions have been asked concerning   
funding for the drug Ivacaftor (“New cystic fibrosis drug ivacaftor (Kalydeco) to be 
made available for Irish patients | Department of Health,” 2013), and are being put 
forward as a newer drug, Orkambi, becomes available. With limited resources, 
healthcare decision makers are being forced to do more with less. Evaluation of 
quality programmes is an important step in determining the effectiveness of an 
intervention. Øvretreit and Gustafson argue that large-scale national quality 
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initiatives are resource heavy, and very often the effectiveness of such programmes 
is not researched or evaluated correctly (Øvretveit & Gustafson, 2003).  They 
suggest that such research is not undertaken due to the large scale complex nature 
of healthcare systems, however, similar to the HSE change model, they emphasise 
that this research is beneficial in identifying factors for successful implementation.  
 
The World Health Organisation (WHO) European working group on Health promotion 
evaluation has defined evaluation as “the systematic examination and assessment of 
the features of an initiative and its effects, in order to produce information that can be 
used by those who have an interest in its improvement or effectiveness” (World 
Health Organisation, 1998 p3). Patient care and quality are at the heart of the HSE, 
and evaluating quality initiatives is important to ensure appropriate standards are 
maintained and outcomes achieved. Evaluation and learning have been incorporated 
into the mainstreaming step of the HSE change model. The purpose of this step is to 
put in place ways to evaluate how the change process was designed and 
implemented. The focus is on improving an organisation’s readiness to engage in 
future change and to discontinue any activity that no longer serves the needs of the 
new organisational reality (Improving our services: A user’s guide to managing 
change in the Health Service Executive, 2008). 
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4.3 Evaluation 
 
4.3.1 Aims 
 
The aim of this OD project was to introduce an adult sweat test clinic in a DATH. The 
degree to which this aim was achieved was determined by evaluating the objectives 
set out in chapter one. The project was evaluated using the CIPP model (figure 2), 
with quantitative measures of evaluation used where appropriate. The CIPP 
evaluation model was originally developed by Daniel Stufflebeam in the 1970’s to 
provide timely information in a systematic way for decision making (Stufflebeam, 
1971). Stufflebeam’s CIPP evaluation model is a framework for conducting formative 
and summative evaluations of projects, personnel, products, organisations and 
evaluation systems (Stufflebeam & Shinkfield, 2007).  It is an improvement model 
designed to systematically guide both evaluators and stakeholders in posing relevant 
questions and conducting assessments. This is done at the beginning of a project 
(context and input evaluation), while it is in progress (input and process evaluation), 
and at the end of the project (product evaluation) (Zhang et al., 2011). Evaluation of 
the change using the CIPP model is discussed in the methods and measures and 
results sections.  
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Figure 2: CIPP evaluation model 
 
 
4.3.2 Methods and Measures 
 
Context 
 
The rationale and triggers for change are at the core of context evaluation. The 
objective of this stage is to assess the overall environmental readiness of the change 
and to assess whether existing goals and priorities are attuned to needs 
(Stufflebeam, 2003). The rationale and triggers for this OD project were described in 
chapters one and three with the context of the change established during the 
initiation phase of the HSE change model. A driving force or trigger for this change 
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was an increase in the demand for adult sweat test services. The demand arose 
from two avenues. Adult patients receiving the CF drug Ivacaftor require an annual 
sweat test to determine the effectiveness of the drug, and reported increases in the 
number of mild cases of CF diagnosed in adults (Farrell et al., 2008) led to an 
increase in the number of referrals from respiratory consultants. This highlighted the 
importance of access to services, identified as a theme in the literature review.  Adult 
CF centres would previously have had no requirement to perform a sweat test as 
patients attending the CF clinics would have been diagnosed as children. They may 
not have access to the appropriate equipment or required training. A medical 
scientist performs the sweat test procedure and analysis facilitating same day TAT 
for results, which had been agreed at a national level by the CF newborn screening 
programme. Due to the increase adult referrals and in discussion with the paediatric 
CF Department a separate location was sought for the adult clinic. 
  
 
Inputs 
 
During input evaluation experts, evaluators and stakeholders identify potentially 
relevant approaches (Zhang et al., 2011). The input evaluation asks “How should it 
be done?” and identifies strategies that are most likely to achieve the desired 
outcome. The result of the input evaluation was a project designed to meet the 
identified needs. This was done by critically examining all relevant approaches and 
recommending alternative designs. The literature review outlined in chapter two was 
one tool used to identify and assess approaches to the change. The implementation 
plan (Table 1), required as part of the HSE change model, was also an important 
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step in the input evaluation as it focused on how best to bring about the proposed 
change.  
 
 
Table 1: Implementation plan 
 
 Perform a literature review 
 Draw up an implementation plan (GANNT chart) 
 Perform a SWOT analysis 
 Perform a stakeholder analysis 
 
 
 
Alternative approaches to this OD project were considered at the initiation phase. 
The current procedure in the organisation was for the sweat stimulation and analysis 
to be performed by a trained medical scientist in the Paediatric OPD. All equipment 
required was located in the sweat test room. This allowed for the collection and 
analysis to occur in tandem, facilitating the stated TAT of results. As the paediatric 
setting was not suitable for adult patients’ consideration was given to the sweat 
stimulation procedure being performed off-site where possible. The sweat test within 
the organisation has, since September 2015, achieved Irish National Accreditation 
Board (INAB) accreditation to ISO 15189:2012, the International Organisation for 
Standardisation standard for medical laboratories. Splitting the sweat test procedure 
across sites would result in unknown pre-analytical variables that could potentially 
impact on the sweat test results. This approach would have not previously been 
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undertaken by the Laboratory and as such was deemed to be high-risk regarding 
potential for error and impacting an already standardised procedure. Current 
guidelines for sweat testing advise that staff performing sweat tests must perform a 
minimum number of sweat tests per annum to maintain competency (Guidelines for 
the Performance of the Sweat Test for the Investigation of Cystic Fibrosis in the UK 
2nd version, 2014). If the stimulation part of the procedure were split across an 
increased number of centres, it would be unlikely that this minimum number would 
be achieved. Maintaining the current procedure was in keeping with guideline 
recommendations (Guidelines for the Performance of the Sweat Test for the 
Investigation of Cystic Fibrosis in the UK 2nd version, 2014), which is a focus of the 
input evaluation. 
 
The volume of sweat collected is checked by the medical scientist before the patient 
leaves the clinic. In cases where insufficient sweat has been collected, a second 
stimulation would be performed on the same day, thus reduceing the callback rate 
for patients. Transporting such small volume biological samples was also considered 
if it was decided that the stimulation procedure would take place in an external 
hospital. Upon review of both the potential pre-analytical issues with the alternative 
proposal and the referrals received it was decided that the current procedure for 
sweat test appointments in the organisation should be followed. As the adult referrals 
had come from nationwide locations, it would not be feasible to implement the sweat 
collection protocol in all locations. This decision was undertaken in consultation with 
the Clinical Chemistry Consultant Pathologist, the Clinical Chemistry Chief Medical 
Scientist and the change agent.   
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Process 
 
The process evaluation stage of the CIPP model allows for evaluation with regard to 
the project, assessing the extent to which it is being carried out appropriately (Zhang 
et al., 2011). Continual evaluation is also supported and recommended with the HSE 
change model, ensuring the change undertaken was achieved. Process evaluation 
may also identify unintended outcomes as a result of the change. It involves the 
actual assessment of the implementation of the change (Frye & Hemmer, 2012). 
This section of the evaluation looks at how the change was implemented compared 
to the plan. It focuses on the problems encountered during the implementation. The 
HSE change model in effect guides the process evaluation step as it encourages on-
going assessment of the project, as discussed in the evaluation of objective one 
where the capacity of the adult clinics was reviewed and increased. The process of 
implementing the change was discussed in detail in chapter three and learnings from 
the process will be further developed in the final chapter.  
 
 
Products 
 
Product evaluation identifies and assesses the outcome of the change to determine 
whether it achieved what it set out to do (Zhang et al., 2011). It is possible that poor 
implementation may cause poor or unintended outcomes (Frye & Hemmer, 2012). 
The SMART objectives set out in chapter one will be evaluated in the results section 
to inform the final part of the CIPP evaluation, the product component. Assessment 
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of the achievement of stated objectives is one method of carrying out a product 
evaluation (Frye & Hemmer, 2012). 
 
 
 4.3.3 Results 
 
Objective 1: A review of adult sweat test requests and current paediatric 
appointments to be conducted by 25th October 2015. 
 
A review of all sweat test requests was performed before the introduction of the adult 
service. This review was used to determine if any additional resources would be 
required, and also to review the number of appointments requested for patients 
already diagnosed with CF. As discussed in chapter one, CF patients have additional 
infection control and health and safety requirements when attending clinics. This 
review identified the weekly paediatric sweat test clinic as having the potential to 
move to every second week, as the weekly clinics were not being filled and there 
was no waiting list for paediatric sweat test appointments. A meeting was held with 
the Chief Medical Scientist, Consultant Chemical Pathologist, a Senior Medical 
Scientist taking over responsibility for the sweat test service and the change agent. It 
was decided that the paediatric Tuesday clinic would be reduced to every second 
Tuesday, allowing the adult clinics to be delivered on alternate Fridays. The clerical 
officers involved in scheduling the appointments were informed of the change. The 
appointment list was monitored to ensure the change did not impact negatively on 
the paediatric service. 
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It was initially hoped that the adult waiting list would be validated to confirm the 
number of adult appointments required. However, not all referral letters contained 
patient contact details. It was decided instead that appointments would be sent to all 
patients, with the laboratory contact details on the letter should the appointment not 
be required. As of March 21st 2016, 2 out of the 33 adult appointments had been 
cancelled, a 6% reduction in demand. When further investigated, one patient had a 
sweat test performed in a hospital outside the region. The patient was living closer to 
the hospital in which the sweat test was performed, and the hospital also provides 
adult CF services. The second cancellation was no longer deemed necessary by the 
requesting consultant.  The number of adult patients attending each clinic was 
initially set at three, as with the paediatric clinic. However, upon a review after the 
completion of two adult clinics, it was felt that the adult patients would produce sweat 
quicker than children and so would require fewer repeat stimulations. The number of 
adult appointments was then set at four for each clinic. Increasing capacity by 30% 
at each clinic would also reduce the wait time for appointments. 
 
 
Objective 2: By 20th January 2016, 100% of appropriate clerical staff would be 
trained on the hospital patient management system (PIMS), used for 
appointment management. 
 
Training for clerical staff using PIMS was carried out during the planning phase of 
the project. During the initiation stage, the rostering system for clerical staff in 
pathology underwent a change. A rotational system meant that additional clerical 
staff would require training for appointment management on PIMS. Prior to this the 
65 
 
sweat test appointment service was overseen by one clerical officer. The training 
requirements were discussed and agreed with the laboratory administrator to ensure 
the clerical officers would receive sufficient training and be competent in booking 
appointments. It was decided that the level 7 clerical officer in Clinical Chemistry 
would attend the training and would then be responsible for training the level 6 
clerical staff as they rotated into the Clinical Chemistry office. Once the training 
needs were identified, the PIMS administrator within the organisation was contacted 
to arrange a training seminar. A mandatory programme on the use of PIMS had 
been attended by all clerical staff and was delivered as part of the organisations 
centre for learning and development education programmes. These programmes are 
revised annually to align with the training needs of the organisation. A prospectus is 
published each year detailing the programmes available to staff, which may be 
compulsory or optional courses, based on requirements. The PIMS administrator 
delivered a course on waiting list management and appointment scheduling to the 
level 8 clerical officer. This information then fed in to the updated standard operating 
procedure (SOP) for sweat test appointments. The SOP was updated by the author 
in consultation with the clerical officers to reflect the adult and paediatric sweat test 
booking procedure, ensuring a standardised procedure existed for booking sweat 
test appointments. As the clerical officers rotated into the Clinical Chemistry 
Department they read and signed the SOP to demonstrate they understood the 
procedure. Operator competence for booking appointments was demonstrated as 
the ability to book a patient appointment. 
 
As the adult clinic had not previously existed, there was no template for the clinic 
present on PIMS. It became apparent that the clinic templates on PIMS would 
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require updating to enable the scheduling of adult and paediatric appointments. A 
meeting was held with the PIMS administrator, the clerical officer, and the change 
agent to agree the format of a new booking system. This would allow both the adult 
and paediatric clinics to be identified on the system and also feeds into the hospital 
management system for waiting lists. Once the clinic templates were activated, and 
the training had been delivered, the clerical officer was capable of placing patients 
on the appropriate waiting list once the referral was received, before booking them 
into a selected date for the sweat test appointment.  
 
 
Objective 3: Activity-based funding for each sweat test would be calculated by 
14th March 2016. 
 
This task was completed by March 7th 2016 (Appendix 4) with the intention of a 
service level agreement being set up with external organisations availing of the adult 
service. This was outside the scope of the current OD project, but will be discussed 
in chapter five in relation to recommendations from the change project. Based on the 
review of services performed in objective 1, the implementation of an adult clinic on 
alternate Fridays was deemed cost neutral as the paediatric clinic had also been 
reduced. If demand for the clinic increased or if there was an increase in the demand 
for paediatric appointments requiring the reintroduction of weekly paediatric clinics, 
the service would need to be reviewed again to determine the cost of increasing 
demands. Access to services was discussed in relation to the literature review in 
chapter two, and with increasing demands across healthcare, service requirements 
are increasing. The ABF for the sweat test service will be available to the HSE as 
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providers become funded for the activity within their organisations (Health Service 
Executive, 2015a). 
 
 
Objective 4: From 28th March 2016, an appointment wait time of eight weeks for 
all adult sweat test appointments would be achieved. 
 
At the implementation stage of the project, 32 adults were on the waiting list awaiting 
appointments. During this stage, a further three adult referrals were received. Two 
appointments were cancelled leaving a total of 33 adult patients on the waiting list. 
Appointments were scheduled on appointment booking sheets devised by the 
clerical staff in clinical chemistry. The appointment letters were then sent to patients 
six weeks before their scheduled appointment. 11 of the patients were CF patients, 
and as discussed in chapter three, communication was required with the external 
referring organisation to ensure these patients were appropriately managed. A delay 
in receiving communication from the referral site meant that these patients remained 
on the waiting list. As these patients had CF, the plan was to cohort them based on 
information provided by the referring hospital. This would allow the four appointment 
slots to be filled efficiently. Without this information, the patients would have to be 
given individual appointments, allowing only one patient to be seen at each clinic. 
This would impact on the overall delivery of the service and would also impact on the 
appointment waiting time for other patients.  A CF nurse from the referral site contact 
the Department in the middle of March, and the cohort information was provided. By 
the end of March 2016, during the project evaluation stage, 14 adult sweat tests had 
been performed with two positive patients identified within this 14 (Figure 3). A 
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further 19 patients were scheduled, with appointments planned up to 26th August 
2016. Many of the later appointments had one or two patients scheduled. These 
consisted of the CF patients from the external referral centre. The next available 
appointment for non-CF referrals received from March 28th 2016 was 20th May 2016, 
which was within the eight-week target set in objective 4. The waiting list for adult 
sweat test appointments was also eliminated as new patients being referred could be 
given an immediate appointment.  
 
 
 
1= Percentage of adults scheduled for appointments (n=19) 
2= Percentage of adult sweat tests performed (n=14) 
3= Percentage positive patients (n=2) from number of adult sweat tests performed (n=14) 
 
Figure 3: Pie chart of adult sweat test appointments 
 
 
 
1
58%
2
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3
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SWEAT TEST APPOINTMENTS
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4.3.4 Dissemination Plan 
 
As discussed in chapter three a reduction in staff numbers maintaining the sweat test 
rota has placed increased pressure on the service as a whole. An increase in the 
number of patients eligible for Ivacaftor and the impending release of Orkambi would 
also place additional demands on the service. Post implementation of the adult 
sweat test service it was proposed that a review of the current service would take 
place to estimate future staffing requirements based on current and projected 
activity. The change agent, in consultation with the business manager of the 
Paediatric Directorate within the organisation and the Consultant Chemical 
Pathologist, will carry out this review. The ABF used to calculate the cost of a sweat 
test appointment has been given to the finance department for verification with the 
intention that it may then be used to fund the service. The Clinical Director for 
Laboratory Medicine was informed of the clinic implementation by the change agent 
as any request for additional resources in the future resulting from an increase in 
clinic demand would require approval at the Directorate level. 
 
Dissemination of the project is also important in terms of organisational learning and 
quality improvement. The evaluation step in the change process is central to this as 
it allows an organisation to understand the impact of an initiative in terms of the 
outcomes and products of change. Further dissemination will occur through the 
authors presentations at relevant conferences, and the final thesis will be made 
available to Royal College of Surgeons in Ireland (RCSI) epublications.  
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4.4 Summary and Conclusion 
 
The aim of this OD project was to introduce an adult sweat test clinic supported by 
four key objectives. A trigger for the change was an increase in the number of adult 
referral letters requesting a sweat test. The purpose of this chapter was to discuss 
the importance of evaluation in healthcare initiatives and the evaluation processes 
undertaken to evidence achievement of the stated aims and objectives this OD 
change. The aim of the project has been achieved, with patients now able to attend 
for appointment within eight weeks of the referral letter being received and the 
elimination of the adult waiting list. 
 
 
5.0 Discussion and Conclusions 
 
5.1 Introduction 
 
The process of OD is concerned with systems-wide learning and change. As 
discussed in the preceding chapters the aim of this project has been achieved 
guided by the HSE change model and evaluation of the process using the CIPP 
evaluation model. The following chapter will discuss the implications and impact of 
the project including the project’s strengths and weaknesses. This is an important 
step in any change process as it provides information for the stakeholders and 
management within the organisation and the individual leading the change. 
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Information and recommendations from this change may then be taken into 
consideration as new change projects are undertaken. 
 
 
5.2 Project Impact 
 
5.2.1 Stakeholders 
 
The introduction of an adult sweat test service has given patients and consultants 
access to a diagnostic service previously not available in the region. As detailed in 
chapter two a large volume of literature exists in relation to access to services. One 
important consequence accessibility can have on a patient is an increase in anxiety 
and improving access can improve satisfaction rates (Carey et al., 2014). This is a 
critical consideration in particular when discussing access to a diagnostic service 
such as a sweat test. In addition to the two positive sweat tests that were reported it 
is important to recognise the impact on those patients previously on a waiting list for 
sweat test appointments. Due to the nature of the diagnostic test the Laboratory has 
always sought to keep wait times to a minimum. As the adult clinic was not 
previously available, 33 adult patients were awaiting appointments with no 
scheduling of dates possible. In this regard, it is important to recognise the role each 
of the stakeholders had in ensuring the clinic was successfully implemented.   
 
The number of adults awaiting sweat tests during this project had not required 
additional resources. However, any increase in demands would need to be 
monitored to ensure the Department is capable of meeting them and to ensure the 
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service does not begin to increase in cost. This was important to convey to the 
Medical Scientists affected by the change. As previously discussed, a number of 
factors led to a reduction in staff performing the sweat tests. It is hoped that by the 
end of 2016 three additional scientists will be trained in the procedure, relieving 
current pressures on the rota.  
  
The change process has also impacted the author. Putting theory into practice and 
applying the tools of organisational development in a practical setting has increased 
the authors understanding of their strengths and areas for improvement. Having an 
understanding of change, reactions to change and tools for overcoming barriers has 
in the authors opinion been an invaluable experience. The knowledge gained from 
the process is further expanded on in the reflective pieces documented throughout 
the change.  
 
 
5.2.2 Practice 
 
Having access to an adult sweat test clinic will now enable symptomatic patients to 
undergo appropriate testing. This will ensure that any patients identified as having a 
sweat chloride suggestive of CF receive the correct care. Confirmation of the 
diagnosis of CF is important as it enables access to CF centre-delivered care and 
CF-specific therapies (Simmonds, 2013).  Optimum care for people with CF is 
defined by the European Consensus document (Kerem, Conway, Elborn, Heijerman, 
& Committee, 2005). Implementing the adult clinic also resulted in a review of the 
paediatric services, as outlined in the evaluation of objective 1. The demand for 
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clinics had reduced which enabled the adult clinic to run without an increase in staff 
resources required. This reduction in the paediatric service is in accordance with the 
literature which finds that improving access can be done by restructuring services 
(Berwick et al., 2008). 
 
 
5.2.3 Theory 
 
Before commencing the project, a literature review as detailed in chapter two, was 
performed to guide the change. The search highlighted some important themes, 
including governance and access to services. The information gathered throughout 
the review formed the basis for the project and identified important aspects in 
implementing the change. Applying the theory of organisational development itself 
has in the authors opinion helped in achieving the change. The change agent 
benefited from understanding the theory behind organisational change. Although 
having a high interest in the change, it was important also to listen to other people’s 
views and be inclusive during the process. As discussed in chapter three, change 
agents build resistance by not communicating enough. It is vital that the change 
agent can detach from emotive situations to build constructive discussions that will 
overcome barriers. The benefit of on-going communication with all stakeholders 
became evident as the change progressed as is discussed throughout the reflective 
pieces. 
 
The development of an adult sweat test service required engagement and 
communication across a number of departments within the organisation as well as 
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with external organisations. As described by Coch and French, communication is the 
responsibility of the change agent when leading OD (Coch & French, 1948). The 
change agent is the driving force behind the project, and it is their responsibility to 
communicate the vision for the future state to all involved. Kotter reasons that under 
communicating the vision for change may impede a project’s success (Kotter, 1995). 
Communication and engagement were key aspects of this OD process, in particular 
with the external organisations as their input was required to schedule appointments. 
Although there was a delay in communication being established, it is hoped that the 
relationships formed as part of this process can be maintained and developed. It is 
the author’s experience that the degree to which a change initiative is achieved is 
dependent on the level of communication throughout the change, as evidenced in 
the literature (Armenakis & Harris, 2009; Coch & French, 1948). 
 
 
5.3 Strengths of the project 
 
One strength of the project was the development of an adult sweat test service, for 
which there was a demand. In the first weeks of the service being available, two 
patients had a sweat chloride result indicative of CF. As discussed during the 
literature review in chapter two access to diagnostics and healthcare services is 
important to ensure patients receive correct diagnoses and treatment. These 
patients have since been referred to adult CF treatment centres, the appropriate care 
pathway, where they will receive care and treatment specific to CF. Increasing the 
capacity at each adult clinic also improved the appointment wait time for patients. 
This increase had been suggested by another staff member once they had delivered 
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an adult clinic. This can be seen as the positive effect engagement, and participation 
has amongst staff and within departments. It is an important learning from this 
change project where engagement, as discussed in the reflective pieces and the 
literature review, is particularly important in healthcare. 
 
Although it may also be considered a limitation, having a time-bound element to the 
change kept the momentum going to achieve the aim. Many change initiatives lose 
impetus, particularly where resistance or difficulties are encountered. In the author’s 
opinion, the time-bound element kept the project focused throughout and using the 
HSE change model gave structure to the project. The time-bound element forced the 
author to be clear with the aims and objectives at the initiation stage of the project. 
The initial proposal was wider reaching, however, to ensure the project was 
completed within the required time frame the scope of the project was reduced 
before the initiation stage. This is a learning that the author will take forward to other 
projects. Although some organisational projects cannot be scaled down, it is 
important to be realistic about what can be achieved with the time and resources 
available. This, in the author’s opinion, also helps with the culture of change and the 
openness of others to change. If initiatives are continually introduced but not 
completed, or where proposals lose momentum and are not clearly communicated, 
staff lose confidence in those promoting change and reluctance may develop.  
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5.4 Limitations of the project 
 
The location of the adult sweat test clinic may be considered a limitation of the 
project. The analysis equipment is located in the paediatric sweat test room which 
enables the medical scientist to perform the sweat stimulation and analysis in the 
one location. The paediatric sweat test department may use the paediatric sweat test 
room on Fridays when it may also be required by the medical scientist to perform the 
sweat analysis. Currently, the scheduling officer in charge of the paediatric rooms is 
contacted by email to advise of the dates the room will be required. Up to the 
evaluation stage, there has not been a conflict with scheduling and the room has 
been available to the scientist to perform the analysis. Long-term, this solution is 
possibly not the most efficient way of operating as the senior medical scientist must 
remember to contact the paediatric scheduling officer to ensure the room will be 
available for the analysis of the sweat samples. This may be revisited by the change 
agent using experience and learning’s from the project.  
 
 
5.5 Recommendations 
 
The sweat test remains the gold standard for the diagnosis of CF (Mattar, Leone, 
Rodrigues, & Adde, 2014). Historically, CF has been mainly confined to children. As 
the survival rate increases and milder forms of the disease are recognised the 
number of requests for adult sweat tests has been increasing (Woods, 2013). The 
quantitation of sweat chloride is the main diagnostic marker. Sweat sodium and 
conductivity may also be reported. In this organisation, sweat conductivity is reported 
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with the sweat chloride result. The reference intervals for each of these tests were 
generated from children, and the diagnostic classifications have been accepted 
independently of age. An unexpected outcome of the project was the wide variability 
in sweat conductivity ranges for adult patients, with many sweat conductivity values 
reading higher than would be expected. The sweat conductivity results in the adult 
patients tested did not always correlate to the sweat chloride result. A study to 
determine sweat conductivity ranges in asymptomatic adults might be considered to 
investigate whether the variation observed in the symptomatic adults tested so far is 
present in the adult population as a whole. The Laboratory is involved in student 
training and assisting students in completing a thesis as part of their undergraduate 
and postgraduate studies. As the organisation has links with an academic partner a 
project such as this may be undertaken by a student completing one of their 
programmes. 
 
A second recommendation would be to develop service level agreements (SLA’s), 
where necessary, with the external organisations. Section 4.4.1 of ISO 15189:2012 
states the requirements for a laboratory entering an agreement to provide a 
laboratory service (International Standard ISO 15189 Medical laboratories- 
Requirements for quality and competence, 2012). Service agreements are reviewed 
periodically and may include such detail as the approximate number of requests to 
be sent to the laboratory. The service agreement can benefit both the requesting 
organisation and the service provider as it allows for review should the terms of the 
agreement change. This will be important should the demand on the adult sweat test 
service increase. It will also provide a means of funding using the costs calculated as 
part of objective 4. A meeting has been held with the author, the Chief Medical 
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Scientist and the Consultant Chemical Pathologist to initiate the process of 
developing an SLA.  
 
As with any quality initiative continuous review is essential to ensure objective and 
aims are being met. This initiative was developed due to increased demand for adult 
services. What is needed now may not be required in five years’ time. Monitoring 
demand and resource is therefore essential to ensure the clinic is being delivered in 
the most efficient and safe manner for patients. This will be reported on monthly 
through the Clinical Chemistry Operational Group meeting within the Laboratory.  
 
 
5.6 Summary and Conclusion 
 
OD recognises that change is an on-going process based on action research. Use of 
a structured model to guide change forces the change agent to continuously reflect 
and refer to evidence-based literature when implementing change. This is 
particularly relevant to a large healthcare organisation. While the project can be used 
to guide further initiatives, the theory behind it is also important to disseminate as a 
means of introducing successful change, demonstrating the importance of leadership 
when guiding change and the need for governance structures to ensure any initiative 
is for the good. The success of the change will be determined by the willingness of 
the department to carry it forward, integrating it into the routine operation of the 
organisation. 
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7.0 Appendices 
 
Appendix 1: SWOT analysis 
 
Strengths Weaknesses 
 Paediatric clinic is currently 
in place 
 The laboratory has all the 
necessary equipment and 
trained and experienced 
staff 
 The hospital is a referral 
centre for the newborn 
screening programme 
 An additional clinic may 
impact on current staff 
resources 
 Any increase in spending in 
providing the service may 
limit the capability to run the 
clinic 
 
Opportunities Threats 
 The hospital could 
potentially become the 
regional referral centre for 
adult and paediatric 
appointments 
 Involvement in any future 
studies or trials for cystic 
fibrosis 
 The cost of providing each 
appointment will be 
determined, providing the 
hospital with data for activity 
based funding 
 Another adult hospital may 
introduce the service 
 Lack of resources or a 
potential increase in 
spending by the laboratory 
in providing the service may 
prevent the clinic 
developing 
 
 
 
 
 
 
86 
 
Appendix 2: Stakeholder analysis 
 
Key Stakeholders: 
Consultant Chemical Pathologist 
 
Chief Medical Scientist Clinical 
Chemistry 
CF nurses 
 
Laboratory Manager 
Medical Scientists 
 
Patients 
Laboratory clerical staff 
 
Endocrinology Department 
Referring consultants 
 
Paediatric CF consultant 
 
 
High influence/Low interest: 
 
Endocrinology Department 
Paediatric CF consultant 
 
 
 
 
 
 
High influence/High interest: 
 
Consultant Chemical Pathologist 
Chief Medical Scientist Clinical 
Chemistry 
Low influence/Low interest: 
 
Laboratory Manager 
 
 
 
 
 
Low influence/High interest: 
 
CF nurses 
Medical Scientists 
Laboratory clerical staff 
Patients 
Referring consultants 
 
 
    Interest 
 
 
 
In
fl
u
e
n
c
e
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Appendix 3: Force Field Analysis 
 
Driving Forces    Restraining Forces 
Adult waiting list  Additional clerical work  
Change agent  Potential increase in work 
Consultant Chemical  for medical scientists if  
Pathologist   demand increases 
    Potential increase in cost  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Change: 
Adult 
Sweat 
Test Clinic 
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Appendix 4: Activity based funding 
 
 
 
 
 
 
 
 
 
 
Activity based funding - Clinical Chemistry Sweat Test  
Expenditure 
Hours 
per 
patient 
Hours 
per 
week Per hour 
Rate (ex 
PRSI) 
PRSI 
(1.25%) 
Cost Per 
Test 
Secretarial  
 
5 28.6 143 1.25 178.75 
Medical Scientist 2.5 
 
22.42 56.05 1.25 70.0625 
Consultant cover 1 
  
100 1.25 125 
Senior Medical Scientist cover to maintain 
service 
 
2 29.22 58.44 1.25 73.05 
EQA/Service Contract/Electrodes (SET 
COST) 
     
100 
Consumables cost per test (ALLOW FOR 
INCREASES) 
     
120 
Facilities management  
     
100 
Training and Support (2% of staff costs)  
     
7.1498 
Total 3.5 7 80.24 357.49  n/a 774.0123 
              
       Clerical Officer Level VII taken from point 6 53545  
     Senior MS cover taken from midpoint in scale 59222 
     MS cover taken from midpoint in scale 43144 
     Include PRSI/pension 1.25% 
      Figures correct as of March 2016 
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Appendix 5: GANNT chart 
 
GANNT chart for development of adult sweat test service using HSE change 
model: 
 
 
 
 
 
 
 
 
 
 
Sep-15 Oct-15 Nov-15 Dec-15 Jan-16 Feb-16
Initiation
Stakeholder analysis
SWOT analysis
Force field analysis
Activity based funding
Planning
Develop implementation plan
Develop patient information letter
Implement appointment service
Implementation
Implement sweat test service
Mainstreaming
Monitor appointment wait time
Evaluate project aims and objectives
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